Health Catalyst (NASDAQ:HCAT) Earns Buy Rating from Canaccord Genuity Group

Canaccord Genuity Group reiterated their buy rating on shares of Health Catalyst (NASDAQ:HCAT – Free Report) in a research report released on Tuesday, Benzinga reports. Canaccord Genuity Group currently has a $11.00 target price on the stock. Other equities analysts also recently issued research reports about the company. Cantor Fitzgerald reissued an overweight rating and […]

Related Keywords

United States ,Piper Sandler ,Keycorp ,Health Catalyst ,Health Catalyst Inc ,Primecap Management Co ,Analyst Recommendations For Health Catalyst ,Canaccord Genuity Group ,Cantor Fitzgerald ,Vanguard Group Inc ,News Ratings For Health Catalyst Daily ,Wells Fargo Company ,Health Catalyst Price Performance ,Impax Asset Management Group ,Kennedy Capital Management ,Nepsis Inc ,Free Report ,Genuity Group ,Moderate Buy ,Get Free Report ,Asset Management Group ,Capital Management ,Health Catalyst Daily ,